224 related articles for article (PubMed ID: 24080892)
1. [Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions].
Picazo JJ; González-Romo F; García Rojas A; Peréz-Trallero E; Gil Gregorio P; de la Cámara R; Morató ML; Rodríguez A; Barberán J; Domínguez Hernández V; Linares Rufo M; Jimeno Sanz I; Portolés JM; Sanz Herrero F; Espinosa Arranz J; García-Sánchez V; Galindo Izquierdo M
Rev Esp Quimioter; 2013 Sep; 26(3):232-52. PubMed ID: 24080892
[No Abstract] [Full Text] [Related]
2. [Vaccination against pneumococcal infection in adults].
Viejo JL
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():26-8. PubMed ID: 20084346
[No Abstract] [Full Text] [Related]
3. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
Giglio N; Micone P; Gentile A
Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
5. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
Aguilar L; Giménez MJ
Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
[No Abstract] [Full Text] [Related]
6. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
Zangeneh TT; Baracco G; Al-Tawfiq JA
Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
[TBL] [Abstract][Full Text] [Related]
7. [Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination].
Baratali L; Lang PO
Presse Med; 2015 Nov; 44(11):1155-61. PubMed ID: 26363530
[TBL] [Abstract][Full Text] [Related]
8. Vaccines: worth paying for the value returned.
Grabenstein JD
Ann Pharmacother; 2002 Sep; 36(9):1471-2. PubMed ID: 12229878
[No Abstract] [Full Text] [Related]
9. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
[TBL] [Abstract][Full Text] [Related]
10. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Traut V
Dtsch Med Wochenschr; 2008 May; 133(22):1207-8; author reply 1208. PubMed ID: 18491279
[No Abstract] [Full Text] [Related]
11. Pneumococcal vaccination of adults: polysaccharide or conjugate.
Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
[No Abstract] [Full Text] [Related]
12. Pneumococcal infection in adults: burden of disease.
Drijkoningen JJ; Rohde GG
Clin Microbiol Infect; 2014 May; 20 Suppl 5():45-51. PubMed ID: 24313448
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal vaccines in adults: assessing the evolving evidence.
Grabenstein JD; Manoff SB
Vaccine; 2011 Aug; 29(37):6149-54. PubMed ID: 21763386
[No Abstract] [Full Text] [Related]
17. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
[TBL] [Abstract][Full Text] [Related]
18. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
Grijalva CG; Edwards KM
Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
[No Abstract] [Full Text] [Related]
19. Serotype replacement in perspective.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C22-4. PubMed ID: 19545935
[TBL] [Abstract][Full Text] [Related]
20. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.
Grau I; Ardanuy C; Liñares J; Podzamczer D; Schulze MH; Pallares R
HIV Med; 2009 Sep; 10(8):488-95. PubMed ID: 19459987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]